PFAS forever chemicals linked to lower bone density in teenagers, new study finds

A new study has found that early exposure to PFAS, a class of synthetic chemicals used in hundreds of consumer products and industrial processes, is associated with measurably lower bone density during the teenage years. Girls appear to be more affected than boys. The research also found that when the exposure occurs matters, with earlier childhood exposure showing stronger effects on adolescent bone development than exposure during the teen years themselves.

Bone density accumulated during adolescence is not a temporary measure. The skeleton builds roughly 90 percent of its peak bone mass by age 18, and that peak largely determines fracture risk decades later. A meaningful reduction in bone density during this window does not correct itself. Whatever deficit forms during development tends to persist into adulthood, which is why this finding has implications that extend well past teenage health.

What PFAS are and why they are everywhere

Per- and polyfluoroalkyl substances, the full name behind the PFAS abbreviation, are a group of more than 12,000 individual chemical compounds characterized by strong carbon-fluorine bonds that resist breakdown. That chemical stability is why they were useful in the first place. PFAS repel water, grease, and heat, which made them attractive for use in non-stick cookware, food packaging, stain-resistant fabrics, firefighting foam, and a wide range of industrial applications starting in the 1950s.

The same property that makes them durable in products makes them persistent in the environment and in human tissue. PFAS do not break down under normal environmental conditions, which is why they have spread through drinking water supplies, agricultural soil, and the food chain globally. The US Centers for Disease Control and Prevention's National Health and Nutrition Examination Survey found detectable levels of PFAS in the blood of 97 percent of Americans tested in a 2019 to 2020 sampling cycle.

How the study was designed and what it measured

The research drew on data from a longitudinal cohort that collected blood samples from children at multiple points during childhood and then assessed bone mineral density using dual-energy X-ray absorptiometry scans during the teenage years. PFAS blood concentrations were measured at different ages to allow the researchers to assess exposure timing as a separate variable from total exposure level.

The study looked at several specific PFAS compounds, including PFOS, PFOA, PFHxS, and PFNA, which are among the most studied and most commonly detected in human blood. Each compound showed associations with lower bone mineral density, but the strength of the association varied by compound, by the age at which blood was drawn, and by sex. PFOS and PFOA, which were the subject of voluntary phase-outs in the United States beginning in the early 2000s, still showed significant associations because exposure had already accumulated in many participants before those phase-outs took effect.

Why girls appear to be more vulnerable

The sex-specific difference in the study's findings is consistent with what researchers know about how PFAS interact with hormonal systems. PFAS have been shown in prior research to interfere with estrogen receptor signaling and thyroid hormone pathways, both of which play direct roles in bone metabolism. Girls experience a concentrated period of bone accrual tied to estrogen-driven pubertal development, and any disruption to estrogen activity during that window would plausibly have a larger effect on bone density than the same disruption in boys, whose bone development timeline and hormonal drivers are different.

A 2021 study published in the Journal of Clinical Endocrinology and Metabolism found that higher PFOA concentrations were associated with delayed puberty onset in girls, which is itself a risk factor for lower peak bone mass. The new findings sit within that broader pattern of PFAS disrupting the hormonal timing that governs bone development in female adolescents.

The exposure timing finding and why it matters

One of the more specific findings in the study is that earlier childhood exposure appeared to have a stronger association with lower teenage bone density than exposure measured later in childhood. This suggests the effects are not simply a matter of accumulated dose but of when in development the exposure occurred relative to critical windows of bone formation and hormonal maturation.

This kind of developmental window effect has been documented for other environmental exposures, including lead and certain endocrine-disrupting pesticides. The practical implication is that reducing PFAS exposure during the earliest years of life may have disproportionate benefits for skeletal health compared to reductions that happen later in childhood, even if the total lifetime exposure is similar. That framing matters for public health messaging and for regulatory decisions about which exposure pathways to prioritize for remediation.

The biological mechanisms behind PFAS and bone

The biological pathway between PFAS exposure and lower bone density is not yet fully established, but several mechanisms have been proposed and are being actively studied. PFAS have been shown to accumulate in bone tissue in animal models and to interfere with the activity of osteoblasts, which are the cells responsible for building new bone. Research in mice published in Environmental Health Perspectives in 2022 found that PFOS exposure reduced osteoblast differentiation and increased the activity of osteoclasts, which break down bone, effectively shifting the balance toward net bone loss.

PFAS also affect calcium metabolism. Some compounds in the class interfere with vitamin D activation, which is the pathway through which calcium absorption in the gut is regulated. Reduced calcium absorption during adolescence directly limits how much bone mineral can be deposited during the growth years, independent of diet or exercise. The study did not measure vitamin D levels directly, but the authors identified disrupted calcium and vitamin D metabolism as a likely contributing pathway based on existing mechanistic research.

What this means for long-term fracture risk

Lower peak bone mass during adolescence is one of the most consistently identified risk factors for osteoporosis and fragility fractures in later life. The World Health Organization estimates that osteoporosis affects approximately 200 million people worldwide and causes more than 8.9 million fractures annually. Hip fractures in particular carry significant mortality risk, with studies consistently showing that 20 to 24 percent of patients who suffer a hip fracture die within 12 months.

If PFAS exposure during childhood produces a meaningful deficit in peak bone mass, the downstream effect on fracture risk at age 60 or 70 would represent a population-level public health cost, not just an individual risk. The study did not follow participants long enough to measure fracture outcomes directly, but the authors noted that even small reductions in peak bone mineral density, on the order of 5 to 10 percent, are associated with substantially elevated fracture risk in longitudinal bone health studies.

Regulatory context and where PFAS standards stand

The EPA established enforceable maximum contaminant levels for six PFAS compounds in drinking water in April 2024, setting limits for PFOA and PFOS at 4 parts per trillion each. Those are among the most stringent PFAS drinking water limits in the world, though environmental health researchers have noted that many PFAS compounds are not yet covered by the new rules and that drinking water is only one of several exposure pathways, with food packaging, cookware, and indoor dust also contributing meaningfully to total body burden.

The study's authors called for bone density monitoring to be included in ongoing environmental health surveillance programs for children in high-exposure communities, particularly those near contaminated water sources or military bases where AFFF firefighting foam has been used extensively. The next phase of research on this question is expected to use longer follow-up periods to assess whether the bone density deficits seen in adolescence persist into early adulthood or can be partially recovered through dietary and lifestyle interventions.